Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50.49 USD | +2.25% | -0.79% | +41.91% |
May. 10 | Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing | MT |
May. 09 | Crinetics Pharmaceuticals Q1 Net Loss Widens | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
3.89B | - | |||||
49.18B | - | |||||
42.11B | ||||||
40.37B | ||||||
28.85B | ||||||
26.09B |